Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab

The aim of this study was to evaluate whether there were significant sex x time interactions in lipoprotein(a) (Lp(a)) and low-density lipoprotein cholesterol (LDL-C) response to treatment with the Proprotein Convertase Subtilisin/Kexin type 9 inhibitor (PCSK9i) Evolocumab, in a real-life clinical s...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, Gökmen Zararsız, Paolo Lido, Claudio Borghi, Arrigo F. G. Cicero
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2023-12-01
Цуврал:	Biomedicines
Нөхцлүүд:	lipoprotein(a) PCSK9 PCSK9 inhibitor evolocumab women’s health
Онлайн хандалт:	https://www.mdpi.com/2227-9059/11/12/3271
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!